Pacira Biosciences (PCRX) Cash from Financing (Quarterly): -7.65M

Pacira Biosciences, Inc. (PCRX)

36.34 +0.01 (+0.03%) USD | NASDAQ | Oct 16, 16:00

36.34 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2010. Start Trial.

Date	Value
June 30, 2026	-7.65M
March 31, 2026	-59.40M
December 31, 2025	-51.65M
September 30, 2025	-257.48M
June 30, 2025	-57.50M
March 31, 2025	-2.994M
December 31, 2024	-1.955M
September 30, 2024	-2.845M
June 30, 2024	24.98M
March 31, 2024	-2.817M
December 31, 2023	-1.779M
September 30, 2023	-27.79M
June 30, 2023	0.44M
March 31, 2023	-153.90M
December 31, 2022	-58.51M
September 30, 2022	-7.775M
June 30, 2022	-153.66M
March 31, 2022	-181.58M
December 31, 2021	361.41M
September 30, 2021	3.052M
June 30, 2021	5.908M
March 31, 2021	10.32M
December 31, 2020	10.36M
September 30, 2020	209.76M
June 30, 2020	3.464M

Date	Value
March 31, 2020	-1.281M
December 31, 2019	-2.02M
September 30, 2019	1.423M
June 30, 2019	3.737M
March 31, 2019	0.53M
December 31, 2018	3.528M
September 30, 2018	2.982M
June 30, 2018	2.025M
March 31, 2018	0.419M
December 31, 2017	2.28M
September 30, 2017	2.688M
June 30, 2017	2.338M
March 31, 2017	216.86M
December 31, 2016	1.07M
September 30, 2016	0.769M
June 30, 2016	2.381M
March 31, 2016	3.041M
December 31, 2015	2.172M
September 30, 2015	1.823M
June 30, 2015	2.657M
March 31, 2015	3.771M
December 31, 2014	2.407M
September 30, 2014	2.117M
June 30, 2014	111.60M
March 31, 2014	1.783M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks